Billerica, Massachusetts—November 9, 2009—Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools, and services for the global life science industry, today announced the introduction of the redesigned Millex® 13 mm sample preparation syringe filter.
The filter, which is used in tens of thousands of laboratories worldwide to prepare samples for critical techniques, including HPLC, UHPLC, and LC-MS, has been redesigned to provide greater speed and recovery than conventional syringe filters of the same size.
Increasing filtration speed (i.e., the speed at which fluid is forced through the filter) also increases pressure on the filter housing. The new 13 mm filter utilizes a novel, Millipore-patented housing design that withstands higher operating pressures than conventional 13 mm filters (up to 150 psig), and, therefore, allows for faster filtration.
In addition, the new device is low in extractables (i.e., compounds leaching from the device) that can be detected by sensitive analytical instruments. It also has 50% less sample hold-up volume, so more sample is recovered after filtration.
“Device manufacturing cleanliness is especially important given the increasing sensitivity of today’s analytical instruments,” said Rebecca Duguid, Analytical Sample Preparation Product Manager. “The new 13 mm Millex syringe filter is manufactured in a clean room to pharmaceutical standards with fully automated equipment and 100% visual and physical inspection.”
The new 13 mm Millex syringe filter can be used to prepare from 1 to 10 mL of sample. It is available in two pore sizes and four membrane materials: polyethersulfone (PES), polytetrafluoroethylene (PTFE), nylon, and polyvinylidene fluoride (PVDF). The housing is color-coded by membrane type for easy identification. The device is compatible with a wide range of solvents and other chemicals, which makes it well suited for all analytical applications and sample types.
Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, visit www.millipore.com.
